세계의 바이오의약품 수탁제조기관(CMO) 시장 : 기회와 전략(-2033년)

Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033

US $ 5,000 ￦ 7,234,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,851,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,469,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 바이오의약품 수탁제조기관(CMO) 시장은 2018년 112억 8,280만 달러로 평가되었으며, 2023년까지 연평균 13.0% 이상 성장할 것으로 예상됩니다.

생명과학 분야 벤처캐피털 투자의 견고성 향상

생명과학 부문에 대한 벤처캐피털 투자가 꾸준히 증가하면서 바이오의약품 수탁제조기관(CMO) 시장의 성장을 견인했습니다. 생명과학 부문은 생물학 관련 연구개발을 수행하는 기업 및 조직을 의미합니다. 벤처캐피털 투자의 견고성은 모델, 테스트, 시스템의 매개변수 및 가정이 변경되었을 때 제대로 작동할 수 있는 능력을 나타내는 기능입니다. 생명과학 부문에 대한 투자가 증가하면 바이오의약품 제조도 증가할 것입니다. 예를 들어, 2021년 9월 미국 투자 컨설팅 전문회사 JLL에 따르면 영국은 지난 3개월 동안 역대 최대 규모의 벤처캐피털을 유치했으며, 2021년 6월 1일부터 8월 26일까지 19억 파운드가 조달되었습니다. 이 투자로 2021년 영국 전체 YTD(1년 누계)는 42억 5,000만 파운드(약 57억 8,700만 달러)로 2020년 28억 파운드에서 증가하였습니다. 따라서 생명과학 부문에 대한 벤처캐피털 투자의 견조한 증가는 바이오의약품 수탁제조기관(CMO) 시장의 성장을 뒷받침했습니다.

목차

제1장 주요 요약

• 바이오의약품 수탁제조기관(CMO) - 시장 매력과 거시경제 상황

제2장 목차

제3장 목차

제4장 표목차

제5장 보고서 구조

제6장 시장 특징

• 일반적인 시장 정의
• 개요
• 바이오의약품 수탁제조기관(CMO) 시장 정의와 세분화
• 시장 세분화 : 제품별
  • 생물학적 제제
  • 바이오시밀러
• 시장 세분화 : 공급원별
  • 포유류
  • 비포유류
• 시장 세분화 : 서비스별
  • 제조업
  • 충전과 마감 작업
  • 분석과 품질 관리 연구
  • 포장

제7장 주요 시장 동향

• 업무 효율화를 도모하기 위해 인수합병 활동이 증가
• 혁신을 추진하기 위한 시장 진출 기업 간의 전략적 파트너십과 협업
• 신제품이나 신기술 개발에 대한 투자 확대

제8장 바이오의약품 수탁제조기관(CMO) 시장 : 거시경제 시나리오

• COVID-19의 영향 바이오의약품 수탁제조기관(CMO) 시장
• 우크라이나 전쟁의 영향, 바이오의약품 수탁제조기관(CMO) 시장
• 고인플레이션의 영향 바이오의약품 수탁제조기관(CMO) 시장

제9장 세계의 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023년
  • 시장 성장 촉진요인, 2018-2023년
  • 시장 성장 억제요인, 2018-2023년
• 예측 시장 성장, 2023-2028년, 2033년
  • 시장 성장 촉진요인, 2023-2028년
  • 시장 성장 억제요인, 2023-2028년

제10장 세계의 바이오의약품 수탁제조기관(CMO) 시장 : 세분화

• 세계의 바이오의약품 수탁제조기관(CMO) 시장 : 제품별, 실적과 예측, 2018-2023년, 2028년, 2033년
• 세계의 바이오의약품 수탁제조기관(CMO) 시장 : 공급원별, 실적과 예측, 2018-2023년, 2028년, 2033년
• 세계의 바이오의약품 수탁제조기관(CMO) 시장 : 서비스별, 실적과 예측, 2018-2023년, 2028년, 2033년

제11장 바이오의약품 수탁제조기관(CMO) 시장 : 지역·국가별 분석

• 세계의 바이오의약품 수탁제조기관(CMO) 시장 : 지역별, 실적과 예측, 2018-2023년, 2028년, 2033년
• 세계의 바이오의약품 수탁제조기관(CMO) 시장 : 국가별, 실적과 예측, 2018-2023년, 2028년, 2033년

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 상황과 기업 개요

• 기업 개요
• Catalent Inc
• Cytiva
• Rentschler Biopharma
• Boehringer Ingelheim International GmbH
• AGC Biologics Inc

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 인수합병

• Novo Nordisk Acquired Catalent
• Advent International And Warburg Pincus Acquired Baxter's Biopharma Solutions(BPS) Business
• The Biofarma Group Acquired U.S. Pharma Lab
• Wacker Chemie Acquired ADL BioPharma
• Catalent Acquired Metrics Contract Services
• Bora Pharmaceuticals Acquired Eden Biologics
• AstraZeneca Acquired Alexion Pharmaceuticals

제23장 기회와 전략

• 세계의 바이오의약품 수탁제조기관(CMO) 시장, 2028년 : 신규사업 기회가 많은 나라
• 세계의 바이오의약품 수탁제조기관(CMO) 시장, 2028년 : 신규사업 기회가 많은 부문
• 세계의 바이오의약품 수탁제조기관(CMO) 시장, 2028년 : 성장 전략
  • 시장 동향 다른 전략
  • 경쟁 전략

제24장 바이오의약품 수탁제조기관(CMO) 시장 : 결론과 제안

• 결론
• 추천사항
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 인재

제25장 부록

ksm

영문 목차

영문목차

Biopharmaceutical contract manufacturing organization (CMO) is a company that provides manufacturing services to biopharmaceutical companies on a contractual basis. These organizations specialize in the production of biopharmaceutical products such as biologics, vaccines, gene therapies and other complex therapeutics.

The biopharmaceutical contract manufacturing organization (CMO) market consists of sales of outsourcing services provided by third-party companies for drug development and production in the biopharmaceutical industry. These organizations offer services such as cell line development, bioprocess development, formulation, analytical testing and antibody drug development.

The global biopharmaceutical contract manufacturing organization (CMO) market was valued at $11,282.8 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 13.0%.

Increase In The Robustness Of Venture Capital Investments For The Life Science Sector

The increase in the robustness of venture capital investments for the life science sector drove the growth of the biopharmaceutical contract manufacturing organization (CMO) market during the historic period. The life sciences sector refers to the businesses and organizations that conduct research and development on living beings. The robustness of venture capital investments is a feature describing the capacity of a model, test, or system to function correctly when its parameters or presumptions are changed. As the investment in the life science sector increases, there will be an increase in the manufacturing of biopharmaceuticals. For instance, in September 2021, according to JLL, a US-based company specializing in investment consultancy, the record amount of venture capital was raised in the UK over the last three months, with £1.9 billion raised between 1 June and 26 August 2021. This investment brings the UK total for 2021 to £4.25 billion ($5.787 billion) YTD (year to date), up from £2.8 billion in 2020. Therefore, the increase in the robustness of venture capital investments for the life science sector supported the biopharmaceutical contract manufacturing organization (CMO) market growth.

Strategic Partnerships and Collaborations Among Market Players To Drive Innovation

Strategic partnerships and collaborations are a key trend gaining popularity in the biopharmaceutical contract manufacturing organization (CMO) market. Major companies operating in the market are focusing on partnerships and collaborations to strengthen their position in the market. For example, in September 2023, Samsung Biologics, a South Korea-based biotechnology company, announced an expanded strategic agreement with Bristol Myers Squibb, a US-based biopharmaceutical company, to manufacture an antibody cancer drug substance. Under the terms of the new agreement, Samsung Biologics will provide drug substance manufacturing for an antibody cancer drug substance at the company's latest and largest biomanufacturing facility, Plant 4, South Korea. Further, in March 2022, TFF Pharmaceuticals, a US-based clinical-stage biopharma company and Catalent, a US-based provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products, announced a collaboration focused on the development of dry powder formulations of biologics for inhaled delivery using thin film freezing technology. The company collaborates with various CMOs, including those focused-on experimentation and addressing societal needs, to enhance treatment possibilities for patients suffering from a wide range of diseases, utilizing their unique technology.

The global biopharmaceutical contract manufacturing organization (CMO) market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 14.66% of the total market in 2022.

Biopharmaceutical Contract Manufacturing Organization (CMO) Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global biopharmaceutical contract manufacturing organization (CMO) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for biopharmaceutical contract manufacturing organization (CMO)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical contract manufacturing organization (CMO) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider biopharmaceutical contract manufacturing organization (CMO) market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by source and by service.
• Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario - The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the biopharmaceutical contract manufacturing organization (CMO) market.
• Global Market Size and Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.

Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by source and by service in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.

• Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies - Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
• Competitive Dashboard - Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations - This section includes recommendations for biopharmaceutical contract manufacturing organization (CMO) providers in terms of product/service offerings geographic expansion, marketing strategies and target groups..
• Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

• 1) By Product: Biologics; Biosimilars
• 2) By Source: Mammalian; Non-Mammalian
• 3) By Service: Manufacturing; Fill And Finish Operations; Analytical And QC (Quality Check) Studies; Packaging
• Companies Mentioned: Catalent Inc; Cytiva; Rentschler Biopharma; Boehringer Ingelheim GmbH; AGC Biologics Inc
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; Canada; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; biopharmaceutical contract manufacturing organization (CMO) indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Biopharmaceutical Contract Manufacturing Organization (CMO) - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Biopharmaceutical Contract Manufacturing Organization (CMO) Market Definition And Segmentations
• 6.4 Market Segmentation By Product
  • 6.4.1 Biologics
  • 6.4.2 Biosimilars
• 6.5 Market Segmentation By Source
  • 6.5.1 Mammalian
  • 6.5.2 Non-Mammalian
• 6.6 Market Segmentation By Service
  • 6.6.1 Manufacturing
  • 6.6.2 Fill And Finish Operations
  • 6.6.3 Analytical And QC Studies
  • 6.6.4 Packaging

7 Major Market Trends

• 7.1 Increased Merger And Acquisition Activities To Streamline Operations
• 7.2 Strategic Partnerships and Collaborations Among Market Players To Drive Innovation
• 7.3 Growing Investments To Build New Products And Technologies

8 Biopharmaceutical Contract Manufacturing Organization (CMO) Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Biopharmaceutical Contract Manufacturing Organization (CMO) Market
• 8.2 Impact Of The War In Ukraine On The Biopharmaceutical Contract Manufacturing Organization (CMO) Market
• 8.3 Impact Of High Inflation On The Biopharmaceutical Contract Manufacturing Organization (CMO) Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market Segmentation

• 10.1 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Regional and Country Analysis

• 11.1 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.9 China Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 India Market
• 12.12 India Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 India Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Australia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Indonesia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 South Korea Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate Tax Structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
• 13.6 UK Market
• 13.7 UK Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.9 USA Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Biopharmaceutical Contract Manufacturing Organization (CMO) Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.3 Africa Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Segmentation By Service, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Catalent Inc
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Cytiva
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Rentschler Biopharma
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Boehringer Ingelheim International GmbH
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Financial Overview
• 19.6 AGC Biologics Inc
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Novo Nordisk Acquired Catalent
• 22.2 Advent International And Warburg Pincus Acquired Baxter's Biopharma Solutions (BPS) Business
• 22.3 The Biofarma Group Acquired U.S. Pharma Lab
• 22.4 Wacker Chemie Acquired ADL BioPharma
• 22.5 Catalent Acquired Metrics Contract Services
• 22.6 Bora Pharmaceuticals Acquired Eden Biologics
• 22.7 AstraZeneca Acquired Alexion Pharmaceuticals

23 Opportunities And Strategies

• 23.1 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market In 2028 - Countries Offering Most New Opportunities
• 23.2 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market In 2028 - Segments Offering Most New Opportunities
• 23.3 Global Biopharmaceutical Contract Manufacturing Organization (CMO) Market In 2028 - Growth Strategies
  • 23.3.1 Market Trend Based Strategies
  • 23.3.2 Competitor Strategies

24 Biopharmaceutical Contract Manufacturing Organization (CMO) Market, Conclusions And Recommendations

• 24.1 Conclusions
• 24.2 Recommendations
  • 24.2.1 Product
  • 24.2.2 Place
  • 24.2.3 Price
  • 24.2.4 Promotion
  • 24.2.5 People

25 Appendix

• 25.1 Geographies Covered
• 25.2 Market Data Sources
• 25.3 Research Methodology
• 25.4 Currencies
• 25.5 The Business Research Company
• 25.6 Copyright and Disclaimer

관련자료